INSYS THERAPEUTICS INC


Updates from The Motley Fool

Latest updates on Insys Therapeutics from Fool.com.  The Fool has written over 100 articles on Insys Therapeutics.
3 Top Stocks Under $10

Hint: Look to the biotech industry for the best bang for the buck.



Stock Performance

View Interactive INSY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Insys Therapeutics.
Current Price: $6.20
Prev Close: $6.03
Open: $6.05
Bid: $6.00
Ask: $6.20
Day's Range: $5.88 - $6.29
52wk Range: $4.10 - $15.02
Volume: 964,798
Avg Vol 670,582
Market Cap: $455M
P/E (ttm): -2.36
EPS (ttm): ($2.56)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Insys Therapeutics.
CAPS Rating 2 out of 5
 
65 Outperform
11 Underperform
CAPS All Stars
 
8 Outperform
4 Underperform

How do you think Insys Therapeutics will perform against the market?



You pick for Insys Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dr. John Kapoor,PhD, CEO

22% Approve

Based on 26 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Insys Therapeutics.

INSYS THERAPEUTICS INC

  • Exchange: NASDAQ